Authors:
Peyruchaud, O
Winding, B
Pecheur, I
Serre, CM
Delmas, P
Clezardin, P
Citation: O. Peyruchaud et al., Early detection of bone metastases in a murine model using fluorescent human breast cancer cells: Application to the use of the bisphosphonate zoledronic acid in the treatment of osteolytic lesions, J BONE MIN, 16(11), 2001, pp. 2027-2034
Authors:
Olorundare, OE
Peyruchaud, O
Albrecht, RM
Mosher, DF
Citation: Oe. Olorundare et al., Assembly of a fibronectin matrix by adherent platelets stimulated by lysophosphatidic acid and other agonists, BLOOD, 98(1), 2001, pp. 117-124
Citation: O. Peyruchaud et Df. Mosher, Differential stimulation of signaling pathways initiated by Edg-2 in response to lysophosphatidic acid or sphingosine-1-phosphate, CELL MOL L, 57(7), 2000, pp. 1109-1116
Authors:
Boissier, S
Ferreras, M
Peyruchaud, O
Magnetto, S
Ebetino, FH
Colombel, M
Delmas, P
Delaisse, JM
Clezardin, P
Citation: S. Boissier et al., Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases, CANCER RES, 60(11), 2000, pp. 2949-2954
Citation: Qh. Zhang et al., Sphingosine 1-phosphate stimulates fibronectin matrix assembly through a Rho-dependent signal pathway, BLOOD, 93(9), 1999, pp. 2984-2990